Concurrent once-daily versus twice-daily chemoradiotherapy in patients with limited-stage small-cell lung cancer (CONVERT): an open-label, phase 3, randomised, superiority trial.
Faivre-Finn C, Snee M, Ashcroft L, Appel W, Barlesi F, Bhatnagar A, Bezjak A, Cardenal F, Fournel P, Harden S, Le Pechoux C, McMenemin R, Mohammed N, O'Brien M, Pantarotto J, Surmont V, Van Meerbeeck JP, Woll PJ, Lorigan P, Blackhall F; CONVERT Study Team.
Lancet Oncol. 2017 Aug;18(8):1116-1125. doi: 10.1016/S1470-2045(17)30318-2. Epub 2017 Jun 20.
Effect of bilateral supraclavicular postoperative radiotherapy in middle and lower thoracic esophageal carcinoma.
Ren Y, Su C, Zhou Y, Zhao X, Yang CL, Liu YY.
World J Gastroenterol. 2014 Dec 21;20(47):17970-5. doi: 10.3748/wjg.v20.i47.17970.
Esophageal squamous cell carcinoma metachronous to head and neck cancers.
Businello G, Fassan M, Degasperi S, Traverso G, Scarpa M, Angriman I, Kotsafti A, Castagliuolo I, Sbaraglia M, Bardini R, Scarpa M.
Pathol Res Pract. 2021 Mar;219:153346. doi: 10.1016/j.prp.2021.153346. Epub 2021 Jan 27.
Association between dietary behavior and esophageal squamous cell carcinoma in Yanting.
Zhao L, Liu CL, Song QK, Deng YM, Qu CX, Li J.
Asian Pac J Cancer Prev. 2014;15(20):8657-60. doi: 10.7314/apjcp.2014.15.20.8657.
Management of resectable esophageal and gastric (mixed adeno)neuroendocrine carcinoma: A nationwide cohort study.
van der Veen A, Seesing MFJ, Wijnhoven BPL, de Steur WO, van Berge Henegouwen MI, Rosman C, van Sandick JW, Mook S, Haj Mohammad N, Ruurda JP, Brosens LAA, van Hillegersberg R; (MA)NEC group.
Eur J Surg Oncol. 2018 Dec;44(12):1955-1962. doi: 10.1016/j.ejso.2018.07.058. Epub 2018 Aug 2.
Esophageal carcinoma: ex vivo evaluation with diffusion-tensor MR imaging and tractography at 7 T.
Yamada I, Hikishima K, Miyasaka N, Kawano T, Tokairin Y, Ito E, Kobayashi D, Eishi Y, Okano H.
Radiology. 2014 Jul;272(1):164-73. doi: 10.1148/radiol.14132170. Epub 2014 Mar 21.
Comparative Molecular Analyses of Esophageal Squamous Cell Carcinoma, Esophageal Adenocarcinoma, and Gastric Adenocarcinoma.
Salem ME, Puccini A, Xiu J, Raghavan D, Lenz HJ, Korn WM, Shields AF, Philip PA, Marshall JL, Goldberg RM.
Oncologist. 2018 Nov;23(11):1319-1327. doi: 10.1634/theoncologist.2018-0143. Epub 2018 Jun 4.
Thoracic lymph node involvement in adenocarcinoma of the esophagogastric junction and lower esophageal squamous cell carcinoma relative to the location of the proximal end of the tumor.
Mine S, Sano T, Hiki N, Yamada K, Kosuga T, Nunobe S, Shigaki H, Yamaguchi T.
Ann Surg Oncol. 2014 May;21(5):1596-601. doi: 10.1245/s10434-014-3548-2. Epub 2014 Feb 15.
Factors affecting postoperative course and survival after en bloc resection for esophageal carcinoma.
Mariette C, Taillier G, Van Seuningen I, Triboulet JP.
Ann Thorac Surg. 2004 Oct;78(4):1177-83. doi: 10.1016/j.athoracsur.2004.02.068.
Postoperative lymphatic recurrence distribution and delineation of the radiation field in lower thoracic squamous cell esophageal carcinomas: a real-world study.
Du R, Fan S, Wang X, Hou X, Zeng C, Guo D, Tian R, Yang D, Jiang L, Dong X, Yu R, Yu H, Li D, Zhu S, Li J, Shi A.
Radiat Oncol. 2022 Mar 5;17(1):47. doi: 10.1186/s13014-022-01987-7.
